Press release
Nasdaq Scheduled Resumption in Moleculin Biotech, Inc.
NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading in Moleculin Biotech, Inc. (Nasdaq: MBRX) is
About this update from Nasdaq, Inc.
[{"type":"text","content":"NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading in Moleculin Biotech, Inc. (Nasdaq: MBRX) is scheduled to resume on Thursday, May 28, 2020, at 7:00 a.m. Eastern Time. Trading in the company’s stock was halted on May 4, 2020 at 9:25:06 Eastern Time.\n For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site. For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. NDAQO Nasdaq Media Contact:Bianca [email protected] \n\n\nSource: Nasdaq, Inc.","length":1665,"tagName":"div"}]